+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients



Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients



Cancer 103(8): 1693-1700



BACKGROUND. The E-cadherin-mediated cell adhesion system is frequeutly inactivated by multiple mechanisms and is involved in tumor progression in many types of cancer. Recently, the authors reported a novel cell membrane glycoprotein, dysadherin, which has an anti-cell-cell adhesion function and down-regulates E-cadherin.METHODS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011867116

Download citation: RISBibTeXText

PMID: 15751018

DOI: 10.1002/cncr.20984


Related references

Prognostic evaluation of cutaneous malignant melanoma: A clinicopathologic and immunohistochemical study. Journal of Surgical Oncology 70(3): 150-160, 1999

Prognostic significance of dysadherin expression in tongue cancer Immunohistochemical analysis of 91 cases. Modern Pathology 16(1): 221A, 2003

Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. Applied Immunohistochemistry & Molecular Morphology 12(4): 323-328, 2004

Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. Journal of Dermatological Science 64(1): 39-44, 2011

Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell and Tissue Research 351(1): 85-98, 2013

P53 expression in cutaneous malignant melanoma: an immunohistochemical study of 87 cases of primary, recurrent, and metastatic melanoma. Modern Pathology 7(5): 533-535, 1994

Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients. American Journal of Pathology 135(6): 1169-1178, 1989

Immunohistochemical analysis of metallothionein expression in malignant melanoma in Japanese patients. American Journal of Dermatopathology 23(1): 29-35, 2001

Cutaneous regressing/regressed malignant melanoma: a clinicopathologic analysis of 8 cases. Zhonghua Bing Li Xue Za Zhi 42(10): 675-678, 2013

Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma. Melanoma Research 5(2): 101-106, 1995

Immunohistochemical Analysis Of Cutaneous Malignant Melanoma. Pathology 26(1): 16-19, 1994

Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. American Journal of Surgical Pathology 34(2): 216-222, 2010

Caspases and inhibitor of apoptosis proteins in cutaneous and mucosal melanoma: expression profile and clinicopathologic significance. Human Pathology 40(7): 950-956, 2009

Laryngeal mucosal malignant melanoma: A clinicopathologic, immunohistochemical, and ultrastructural study of four patients and a review of the literature. Cancer 75(7): 1568-1577, 1995

Immunohistochemical study of pepsinogen C expression in cutaneous malignant melanoma: association with clinicopathological parameters. International Journal of Biological Markers 16(4): 240-244, 2002